Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.

Roeleveld DM, van Nieuwenhuijze AE, van den Berg WB, Koenders MI.

BioDrugs. 2013 Oct;27(5):439-52. doi: 10.1007/s40259-013-0035-4. Review.

PMID:
23620106
2.

The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.

Roeleveld DM, Koenders MI.

Cytokine. 2015 Jul;74(1):101-7. doi: 10.1016/j.cyto.2014.10.006. Epub 2014 Nov 20. Review.

PMID:
25466295
3.

Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis.

Kugyelka R, Kohl Z, Olasz K, Mikecz K, Rauch TA, Glant TT, Boldizsar F.

Mediators Inflamm. 2016;2016:6145810. doi: 10.1155/2016/6145810. Epub 2016 Jan 20. Review.

4.

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.

Benedetti G, Miossec P.

Eur J Immunol. 2014 Feb;44(2):339-47. doi: 10.1002/eji.201344184. Review.

5.

The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.

Toussirot E.

Inflamm Allergy Drug Targets. 2012 Apr;11(2):159-68. Review.

PMID:
22280236
6.

Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.

van den Berg WB, McInnes IB.

Semin Arthritis Rheum. 2013 Oct;43(2):158-70. doi: 10.1016/j.semarthrit.2013.04.006. Review.

PMID:
24157091
7.

IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.

Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, Wen Z, Huang K, Huang Z.

J Immunol. 2015 Jun 1;194(11):5110-9. doi: 10.4049/jimmunol.1401810. Epub 2015 Apr 27.

8.

Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.

Yamagata T, Skepner J, Yang J.

Arch Immunol Ther Exp (Warsz). 2015 Dec;63(6):405-14. doi: 10.1007/s00005-015-0362-x. Epub 2015 Sep 10. Review.

PMID:
26358867
9.

IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.

Zhu S, Qian Y.

Clin Sci (Lond). 2012 Jun;122(11):487-511. doi: 10.1042/CS20110496. Review.

PMID:
22324470
10.

Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.

Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T.

Clin Dev Immunol. 2013;2013:968549. doi: 10.1155/2013/968549. Epub 2013 Jul 14. Review.

11.

Interleukin-17 in inflammatory myopathies.

Tournadre A, Miossec P.

Curr Rheumatol Rep. 2012 Jun;14(3):252-6. doi: 10.1007/s11926-012-0242-x. Review.

PMID:
22350607
12.

Targeting Th17 cells in autoimmune diseases.

Yang J, Sundrud MS, Skepner J, Yamagata T.

Trends Pharmacol Sci. 2014 Oct;35(10):493-500. doi: 10.1016/j.tips.2014.07.006. Epub 2014 Aug 14. Review.

PMID:
25131183
13.

The IL-17 pathway as a major therapeutic target in autoimmune diseases.

Hu Y, Shen F, Crellin NK, Ouyang W.

Ann N Y Acad Sci. 2011 Jan;1217:60-76. doi: 10.1111/j.1749-6632.2010.05825.x. Epub 2010 Dec 13. Review.

PMID:
21155836
14.

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.

Singh B, Schwartz JA, Sandrock C, Bellemore SM, Nikoopour E.

Indian J Med Res. 2013 Nov;138(5):591-4. Review.

15.

[1,25(OH)2-Vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis].

Wen H, Luo J, Zhang X, Zhang C, Zhao X, Wang X, Li X.

Zhonghua Nei Ke Za Zhi. 2015 Apr;54(4):317-21. Chinese.

PMID:
26268060
16.

Th17 cells in inflammation and autoimmunity.

Singh RP, Hasan S, Sharma S, Nagra S, Yamaguchi DT, Wong DT, Hahn BH, Hossain A.

Autoimmun Rev. 2014 Dec;13(12):1174-81. doi: 10.1016/j.autrev.2014.08.019. Epub 2014 Aug 23. Review.

PMID:
25151974
17.

Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Tang C, Chen S, Qian H, Huang W.

Immunology. 2012 Feb;135(2):112-24. doi: 10.1111/j.1365-2567.2011.03522.x. Review.

18.

The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.

Schinnerling K, Aguillón JC, Catalán D, Soto L.

Clin Exp Immunol. 2017 Jul;189(1):12-20. doi: 10.1111/cei.12966. Epub 2017 Apr 20. Review.

PMID:
28369786
19.

Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.

Azizi G, Jadidi-Niaragh F, Mirshafiey A.

Int J Rheum Dis. 2013 Jun;16(3):243-53. doi: 10.1111/1756-185X.12132. Review.

PMID:
23981743
20.

IL-17/Th17 mediated synovial inflammation is IL-22 independent.

van Hamburg JP, Corneth OB, Paulissen SM, Davelaar N, Asmawidjaja PS, Mus AM, Lubberts E.

Ann Rheum Dis. 2013 Oct;72(10):1700-7. doi: 10.1136/annrheumdis-2012-202373. Epub 2013 Jan 17.

PMID:
23328939

Supplemental Content

Support Center